2m 2m 2m 2m 2m 2m 2m
Repligen (RGEN)
NASDAQ
$145.39+$0.51 (+0.35%)
Price as of Jul 13, 2026 7:59 PM EDT- $8.1BMarket Cap
- 19.41%1-Year Change
- Medical Instruments & SuppliesIndustry
Repligen (RGEN)
$145.39+$0.51 (+0.35%)
RGEN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $144.88 | ||
Change | +$0.64 (+0.44%) | ||
Open | $142.80 | ||
High | $146.69 | ||
Low | $141.64 | ||
Previous Close | $144.24 | ||
Volume | 753,315 | ||
30-Day Average Volume | 1,043,859 | ||
1-Week Change | 2.42% | ||
1-Month Change | 10.94% | ||
1-Year Change | 19.41% | ||
3-Year Change | -2.85% | ||
5-Year Change | -27.87% | ||
Fundamentals | |||
Shares Outstanding | 56.4M | ||
Total Assets | $2.9B | ||
Market Cap | $8.1B | ||
Enterprise Value | $8.1B | ||
Period: QTR TTM FY | |||
Revenue | $194.2M | ||
Net Income | $8.3M | ||
Free Cash Flow | $23.6M | ||
EBIT | $7.6M | ||
EBITDA | $27.4M | ||
Net Working Capital | $1.0B | ||
EPS | $0.15 | ||
Enterprise Value/EBITDA | 296 | ||
Enterprise Value/Revenue | 42 | ||
P/B | 4 | ||
P/E | 962 | ||
PEG | -10 | ||
Price/Free Cash Flow | 345 | ||
Price/Operating Cash Flow | 288 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue